biologics Latest News

The launch of this new addition to the VESUVIUS product family demonstrates K2M’s continued focus on growing our presence in the biologics market

Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...

Variations in global regulatory strategy for biosimilars outside Europe, Japan and the US

100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012.

Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

The launch of this new addition to the VESUVIUS product family demonstrates K2M’s continued focus on growing our presence in the biologics market

Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...

Slim, trim thermal packaging liners save up to 70% on shippers' pallets + shelves compared to foam packaging and coolers, enabling better control of storage requirements. And unlike with foam packaging, the liners are disposable in ordinary trash.

Variations in global regulatory strategy for biosimilars outside Europe, Japan and the US

A new report by visiongain, a London-based business information company, predicts that global revenues for biosimilars will reach $1.6 billion in 2012.

Those that missed last month's event can get a CD with 350 speaker presentations from 16 conferences within 4 scientific channels: diagnostics, drug discovery & development, informatics and cancer. TriConference.com

New report: Regulatory Intelligence on Biologics Recalls: Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes

Those that missed last month's event can get a CD with 80 speaker presentations from 4 pipelines: formulation, purification, biotherapeutics, and expression. Individual track CDs and the overall event CD is available at CHI-PepTalk.com.

Seamlessly Integrated R&D, Production, Sales and Marketing Processes to Ensure Success in this High Growth Market

Vela Laboratories and Anagnostics enter strategic partnership to offer hybcell technology to biotech and pharma customers under GMP conditions.

Kalos Therapeutics, Inc. Co Founder George Colberg to Present at BIOCOM's Global Life Science Partnering Conference 2012, La Jolla, CA, USA,Thursday February 2nd, 2012 Being held at the Lodge at Torrey Pines in La Jolla CA

100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012.

Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

A new global market report on 'Orthopedic Implants' has been released by Industry Experts. According to the report, the global market for orthopedic implants is projected to reach US$ 46.5 billion by 2017 from an estimated US$ 21.1 billion in 2007.

Piribo, the online destination for Pharma intelligence, has added a new report.

Harrisburg University will host a panel “Biologics and Biosimilars” that will bring together key PA-based stakeholders—patient groups, physicians, opinion leaders and the bioscience community—to facilitate a policy discussion on biosimilars.

Within the next five years, the global biologics market is set to exceed $239 billion (£145 billion) in value, according to recent research by Bharat Book.

French and American governments have implemented 2009-2011 tax incentives for drug developers or manufacturers, which bode well for the biopharmaceutical market worldwide, according to healthcare market research firm Kalorama Information in its...

New Healthcare market report from Datamonitor: "R&D Trends: Psoriasis - Pipeline outlook following withdrawal of key regulatory filing"

Recently published research from Datamonitor, "Pharmaceutical Key Trends 2011 - Biosimilar Market Overview", is now available at Fast Market Research

A Primer on IP Basics and Regulatory Fundamentals Relative to Small Molecules and Biologics

We are less than two months away from a must attend educational and networking event for scientific and business leaders involved in drug delivery and formulation to discuss the current challenges and new strategies to succeed in this evolving area.

With cancer costs projected to rise substantially over the next decade, J.P. Farley Corporation is providing their customers in cancer care treatment programs with financial savings.

Fast Market Research recommends "The Global Market for Orthobioligical Products" from Espicom Business Intelligence, now available

Aarkstore.com announce a new report "Global Biosimilars (Follow-on biologics) Market: An Analysis " through its vast collection of market research report.

KT-220 will continue in development under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

Bharatbook added a new report on "Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets" into its market report catalogue for reselling.

Breast cancer accounts for approximately 12% of all cancers worldwide. In the U.S. more than 200,000 people develop breast cancer each year, with more than 95% of these women.

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies

Drug delivery has become an important focus of the industry. Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena.

Bharatbooks new report on "Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies" into its market report catalogue for reselling.

New Pharmaceuticals market report from GBI Research: "Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies"

Bharatbook added a new report on "Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025" which predicts how the biosimilars market will develop from 2010 onwards.

BioMedGPS has announced the introduction of SmartTRAK™ Online Business Intelligence, an electronic platform designed to provide proprietary intelligence on medical device markets, companies and products.

BioPlus Specialty Pharmacy celebrates 12000 square foot expansion and complete pharmacy renovation

GenScript will sponsor the BIT Life Sciences’ 1st Annual International Congress of Antibodies (ICA). CEO Dr. Frank Zhang will give keynote speech to share thoughts on antibody drug development.

Today, URCH Publishing Ltd announces the availability of a major new market report on biologic drugs.

Rhonda Greenapple, president and founder of Reimbursement Intelligence, has recently created a quarterly newsletter aid investors and emerging biotechnology companies in their efforts in preparing for and addressing reimbursement challenges.

GTCbio just announced its holding the annual Modern Drug Discovery and Development Summit taking place on October 15-17, 2008 in San Diego, CA.

Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report, written by leading scientists in the field, which outlines and assesses the implications of patient reactions to biotech drugs.

AGAWAM, MASS. – A new, free white paper, addressing the challenges of new U.S. Food and Drug Administration (FDA) regulations awaiting combination products manufacturers, is now available for download at www.microtestlabs.com/combinationpaper.